Nancy Denyes serves as Executive at aTYR PHARMA INC, where they oversee executive responsibilities. Since joining the company, Nancy Denyes has executed 9 insider transactions totaling $11.6K, demonstrating a bullish approach to their equity position. Their most recent transaction on Feb 4, 2026 involved selling 1,118 shares valued at $1.1K.
Nancy Denyes currently holds 33,124 shares of aTYR PHARMA INC (LIFE), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Nancy Denyes has been a net buyer of LIFE stock. They have purchased $9.3K and sold $2.3K worth of shares.
Nancy Denyes's most recent insider trade was on Feb 4, 2026, when they sold 1,118 shares at $0.98 per share.
Get notified when new Form 4 filings are submitted
| $N/A |
| Discretionary |
| Feb 3, 2026 | ATYR | $0 | Option Exercise | 2,687 | $N/A | Discretionary |
| Jan 9, 2026 | ATYR | $0 | Award | 412,500 | $N/A | Discretionary |
| Jun 5, 2024 | ATYR | $9.3K | Purchase | 5,000 | $1.86 | Discretionary |
| Feb 5, 2024 | LIFE | $0 | Option Exercise | 2,688 | $N/A | Discretionary |
| Feb 3, 2023 | LIFE | $0 | Option Exercise | 2,688 | $N/A | Discretionary |
| May 20, 2020 | LIFE | $1.2K | Sale | 322 | $3.62 | Discretionary |
| May 16, 2020 | LIFE | $0 | Option Exercise | 892 | $N/A | Discretionary |